Acute kidney injury and tools for risk-stratification in 456 patients with hantavirus-induced nephropathia epidemica

Nephrology Dialysis Transplantation

Volumn 30, Issue 2, 2015, Pages 245-251

  Latus, Joerg ^a   Schwab, Matthias ^b,c   Tacconelli, Evelina ^c   Pieper, Friedric Michael ^a   Daniel, Wegene ^a   Rettenmaier, Bianka ^a   Schwab, Andrea ^a   Hoffmann, Larissa ^a   Dippon, Juergen ^d   Müller, Simon ^d   Fritz, Peter ^a   Zakim, David ^a   Segerer, Stephan ^e   Kitterer, Daniel ^a   Kimmel, Martin ^a   Gumann, Karl ^f   Priwitzer, Martin ^g   Mezger, Barbara ^g   Birgit, Walte Frank ^h   Corea, Angela ⁱ   Albrecht, Wiedenman ⁱ   Brockmann, Stefan ^j   Pöhlmann, Christoph ^a   Alscher, M Dominik ^a   Braun, Niko ^a   more..

^a ROBERT BOSCH HOSPITAL   (Germany)

^b DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d UNIVERSITY OF STUTTGART   (Germany)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f General Practitioner   (Germany)

^g State Health Authority   (Germany)

^h Local Health Authority   (Germany)

ⁱ Local Health Authority   (Germany)

^j Local Health Authority   (Germany)

more..

Author keywords

acute kidney injury; hanta virus; nephropathia epidemica; predictors for severe course; PUUV

Indexed keywords

C REACTIVE PROTEIN; CREATININE; BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GERMANY; HANTAVIRUS INFECTION; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; KIDNEY INFECTION; MAJOR CLINICAL STUDY; MALE; NEPHROPATHIA EPIDEMICA; NONHUMAN; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEINURIA; PUUMALA VIRUS; RIFLE CRITERIA; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; ACUTE KIDNEY INJURY; HANTAVIRUS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; METABOLISM; MIDDLE AGED; PATHOGENICITY; PROSPECTIVE STUDY; RISK; SEVERITY OF ILLNESS INDEX; VIROLOGY;

ACUTE KIDNEY INJURY; ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HANTAVIRUS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; PROTEINURIA; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBOCYTOPENIA;

EID: 84922489835     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu319     Document Type: Article

References (46)

1. Kruger DH, Ulrich RG, Hofmann J. Hantaviruses as zoonotic pathogens in Germany. Dtsch Arztebl Int 2013; 110: 461-467
2. Schmaljohn CS, Dalrymple JM. Analysis of Hantaan virus RNA: evidence for a new genus of bunyaviridae. Virology 1983; 131: 482-491
3. Kruger DH, Ulrich R, Lundkvist AA. Hantavirus infections and their prevention. Microbes Infect 2001; 3: 1129-1144
4. Lee HW, Van der Groen G. Hemorrhagic fever with renal syndrome. Prog Med Virol 1989; 36: 62-102
5. Mertz GJ, Hjelle B, Crowley M et al. Diagnosis and treatment of new world hantavirus infections. Curr Opin Infect Dis 2006; 19: 437-442
6. Peters CJ, Simpson GL, Levy H. Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu Rev Med 1999; 50: 531-545
7. Watson DC, Sargianou M, Papa A et al. Epidemiology of hantavirus infections in humans: a comprehensive, global overview. Crit Rev Microbiol 2014; 40: 261-272
8. Vapalahti O, Mustonen J, Lundkvist A et al. Hantavirus infections in Europe. Lancet Infect Dis 2003; 3: 653-661
9. Krautkramer E, Zeier M, Plyusnin A. Hantavirus infection: an emerging infectious disease causing acute renal failure. Kidney Int 2013; 83: 23-27
10. Martinez VP, Bellomo CM, Cacace ML et al. Hantavirus pulmonary syndrome in Argentina, 1995-2008. Emerg Infect Dis 2010; 16: 1853-1860
11. Hjertqvist M, Klein SL, Ahlm C et al. Mortality rate patterns for hemorrhagic fever with renal syndrome caused by Puumala virus. Emerg Infect Dis 2010; 16: 1584-1586
12. Mustonen J, Partanen J, Kanerva M et al. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int 1996; 49: 217-221
13. Korva M, Saksida A, Kunilo S et al. HLA-Associated hemorrhagic fever with renal syndrome disease progression in Slovenian patients. Clin Vaccine Immunol 2011; 18: 1435-1440
14. Laine O, Joutsi-Korhonen L, Makela S et al. Polymorphisms of PAI-1 and platelet GP Ia may associate with impairment of renal function and thrombocytopenia in Puumala hantavirus infection. Thromb Res 2012; 129: 611-615
15. Makela S, Hurme M, Ala-Houhala I et al. Polymorphism of the cytokine genes in hospitalized patients with Puumala hantavirus infection. Nephrol Dial Transplant 2001; 16: 1368-1373
16. Mustonen J, Partanen J, Kanerva M et al. Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand J Immunol 1998; 47: 277-279
17. Libraty DH, Makela S, Vlk J et al. The degree of leukocytosis and urine GATA-3 mRNA levels are risk factors for severe acute kidney injury in Puumala virus nephropathia epidemica. PLoS One 2012; 7: e35402
18. Outinen TK, Kuparinen T, Jylhava J et al. Plasma cell-free DNA levels are elevated in acute Puumala hantavirus infection. PLoS One 2012; 7: e31455
19. Outinen TK, Makela SM, Ala-Houhala IO et al. The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations. BMC Infect Dis 2010; 10: 132
20. Rasche FM, Uhel B, Kruger DH et al. Thrombocytopenia and acute renal failure in Puumala hantavirus infections. Emerg Infect Dis 2004; 10: 1420-1425
21. Krautkramer E, Grouls S, Urban E et al. No gender-related differences in the severity of nephropathia epidemica, Germany. BMC Infect Dis 2013; 13: 457
22. Bellomo R, Ronco C, Kellum JA et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212
23. R Development Core Team (2011) R: A Language and Environment for Statistical Computing. Vienna, Austria : the R Foundation for Statistical Computing. ISBN: 3-900051-07-0. Available online at http://www.R-project.org
24. Zamar D, Brad McNeney, Jinko Graham. elrm: software implementing exact-like inference for logistic regression models. J Stat Softw 2007; 21
25. Sing T, Sander O, Beerenwinkel N et al. ROCR: visualizing classifier performance in R. Bioinformatics 2005; 21: 3940-3941
26. Venables WN, Ripley BD. Modern Applied Statistics with S. New York: Springer, 2002
27. Harrell FE Jr. rms: regression modeling strategies. R Package Version 4.0-0. 2013
28. Gonen M. Analyzing receiver operating characteristic curves with SAS. SAS Publishing; 2008
29. Hastie TTR, Friedman J. The elements of statistical earning-data mining, inference, and prediction. Springer 2011
30. Klein SL, Marks MA, Li Wet al. Sex differences in the incidence and case fatality rates from hemorrhagic fever with renal syndrome in China, 2004-2008. Clin Infect Dis 2011; 52: 1414-1421
31. Mustonen J, Brummer-Korvenkontio M, Hedman K et al. Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis 1994; 26: 7-13
32. Lahdevirta J. Nephropathia epidemica in Finland. A clinical histological and epidemiological study. Ann Clin Res 1971; 3: 1-54
33. Linderholm M, Billstrom A, Settergren B et al. Pulmonary involvement in nephropathia epidemica as demonstrated by computed tomography. Infection 1992; 20: 263-266
34. Kanerva M, Paakkala A, Mustonen J et al. Pulmonary involvement in nephropathia epidemica: radiological findings and their clinical correlations. Clin Nephrol 1996; 46: 369-378
35. Paakkala A, Lempinen L, Paakkala T et al. Medical imaging in nephropathia epidemica and their clinical correlations. Eur J Intern Med 2004; 15: 284-290
36. Mustonen J, Helin H, Pietila K et al. Renal biopsy findings and clinicopathologic correlations in nephropathia epidemica. Clin Nephrol 1994; 41: 121-126
37. Kulzer P, Schaefer RM, Heidbreder E et al. Hantavirus infection with acute kidney failure. Dtsch MedWochenschr 1992; 117: 1429-1433
38. Krautkramer E, Grouls S, Stein N et al. Pathogenic old world hantaviruses infect renal glomerular and tubular cells and induce disassembling of cellto-cell contacts. J Virol 2011; 85: 9811-9823
39. Muranyi W, Bahr U, Zeier M et al. Hantavirus infection. J Am Soc Nephrol 2005; 16: 3669-3679
40. Elgh F, Linderholm M, Wadell G et al. Development of humoral crossreactivity to the nucleocapsid protein of heterologous hantaviruses in nephropathia epidemica. FEMS Immunol Med Microbiol 1998; 22: 309-315
41. Elgh F, Lundkvist A, Alexeyev OA et al. Serological diagnosis of hantavirus infections by an enzyme-linked immunosorbent assay based on detection of immunoglobulin G and M responses to recombinant nucleocapsid proteins of five viral serotypes. J Clin Microbiol 1997; 35: 1122-1130
42. Maes P, Clement J, Gavrilovskaya I et al. Hantaviruses: immunology, treatment, and prevention. Viral Immunol 2004; 17: 481-497
43. Klempa B, Meisel H, Rath S et al. Occurrence of renal and pulmonary syndrome in a region of northeast Germany where Tula hantavirus circulates. J Clin Microbiol 2003; 41: 4894-4897
44. Klempa B, Schutt M, Auste B et al. First molecular identification of human Dobrava virus infection in central Europe. J Clin Microbiol 2004; 42: 1322-1325
45. Ettinger J, Hofmann J, Enders M et al. Multiple synchronous outbreaks of Puumala virus, Germany, 2010. Emerg Infect Dis 2012; 18: 1461-1464
46. Latus J, Tenner-Racz K, Racz P et al. Detection of Puumala hantavirus antigen in human intestine during acute hantavirus infection. PLoS One 2014; 9: e98397